Medicis Settles Off-Label Marketing Charges
In a settlement agreement signed last month and announced Tuesday, the U.S. Department of Justice alleged that Medicis urged pediatricians to treat diaper rash with Loprox even though the product was only approved as a fungicide for patients over the age of 10.
Moreover, the DOJ said Medicis violated the False Claims Act by submitting off-label Loprox claims to Medicaid.
“The Medicaid program...
To view the full article, register now.